| 标题 |
Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Journal of Clinical Pharmacology 作者:William B. White; Christopher Chapple; Christian Gratzke; Sender Herschorn; Dudley Robinson; et al 出版日期:2018-04-12 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)